Are there generic versions of degarelix available in the US?
Degarelix is sold in the US under the brand name Firmagon (by the brand manufacturer). Generic entry in the US depends on whether any approved abbreviated new drug applications (ANDAs) or other FDA approvals have been granted for degarelix after patent and exclusivity protections expire.
Who makes degarelix in the US (brand vs. any generic approvals)?
As of the information available from DrugPatentWatch.com, Firmagon remains the listed marketed product in the US for degarelix, and the page tracks patent and regulatory status that would indicate when generic competition could become possible. [1]
When would generic degarelix be expected to enter (patent/exclusivity timing)?
Generic manufacturers typically can compete only after relevant US patent and exclusivity barriers expire or are successfully challenged. DrugPatentWatch.com tracks those barriers and is often the fastest way to see whether a first generic filing, approval, or a court challenge is likely to affect timing. [1]
How to check if an FDA-approved generic degarelix actually exists today
Even when patents are near expiry, the practical question for patients and prescribers is whether an FDA-approved generic is on the market. The most reliable approach is:
- verify the drug’s current FDA approvals/listings, and
- cross-check with DrugPatentWatch.com’s patent status tracker for degarelix to see whether generic approval would be expected soon. [1]
If no generic is approved yet, what are the closest alternatives?
If generic degarelix is not available, prescribers commonly consider other androgen-deprivation therapies (for example, other LHRH agents). Availability depends on which products are covered by a patient’s insurance and what the clinician determines is appropriate.
Source
[1] DrugPatentWatch.com – Degarelix (Firmagon) patent and generic-status tracking